HT
Hopewell Therapeutics, Inc.
SEC filingBiotechnology · Woburn, MA
Amount raised$2.5Msold at filing
Total offering$3.5M$1M still open
Investors in the raise2count reported to the SEC
FiledSep 17, 2025first sale Sep 2, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Nan V. ShenDirector
Qiaobing V. XuExecutive Officer, Director
Thomas V. Hennessey, IIIDirector
Xutian V. JingDirector
Xiaowen V. FemgDirector
C. Thomas PaschallDirector
Executive officers, directors and promoters as listed on the Form D.